Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CLN-617 |
Trade Name | |
Synonyms | CLN 617|CLN617 |
Drug Descriptions |
CLN-617 is fusion protein comprising IL-2 and IL-12, as well as HSA and LAIR2, which potentially induces antitumor immune response (Cancer Res (2023) 83 (7_Supplement): 1839). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CLN-617 | CLN-617 | 0 | 0 |
CLN-617 + Pembrolizumab | CLN-617 Pembrolizumab | 0 | 1 |